Study to Investigate the Influence of Compression Treatment in Patients With Pelvic Congestion Syndrome (PCS)
1 other identifier
interventional
172
1 country
1
Brief Summary
Pelvic vein embolization (PVE) is the current treatment procedure used to treat women with Pelvic Congestion Syndrome (PCS). This treatment is not widely available, and many women when diagnosed with PCS cannot afford treatment. The purpose of this study is to assess whether compression therapy is an effective alternative treatment to PVE for women who are unwilling or unable to undergo treatment by PVE. Compression therapy would provide a cost-effective alternative to coil embolization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedSeptember 23, 2022
September 1, 2022
2 years
September 1, 2021
September 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Change from Baseline in Quality of Life and Symptoms at one month post-treatment and at two months post-treatment
Patients will fill out a quality of life and symptoms questionnaire at the start of the study (baseline (month 0)). Patients will then undergo treatment after one month. A quality of life and symptoms questionnaire will then be filled out again one month after treatment (end of month 2), and again a month later (end of month 3). This questionnaire uses visual analogue scales to quantify quality of life and the severity of symptoms.
Baseline (start of month 0), 1 month post-treatment (end of Month 2) and two months post-treatment (end of month 3)
Study Arms (2)
Pelvic Vein Embolization (PVE)
ACTIVE COMPARATORPatients will have their pelvic veins embolized in accordance with their personalised treatment plan, based on their trans-vaginal ultrasound scan. These patients form the control group.
Compression Therapy
EXPERIMENTALPatients will wear compression pants (with leg compression if patients also have symptomatic leg varicose veins).
Interventions
Similar to compression stockings for the legs which are designed to apply pressure to improve venous return in the legs, compression pants have been designed to apply pressure to pelvic veins to improve the symptoms of Pelvic Congestion Syndrome.
Embolization coils are used to block the veins they are positioned in. This is a standard treatment offered to patients at The Whiteley Clinic.
Eligibility Criteria
You may qualify if:
- Females aged 18 - 65 years
- Having one or more symptoms of PCS
- Symptoms: Aching / dragging in pelvis on sitting and/or standing, aching/tender /painful vulval varicose veins, irritable bowel, irritable bladder, deep dyspareunia, low back pain, hip pain with no or very mild changes on hip x-ray.
- Able to understand study and give written consent.
- Able to have trans-vaginal ultrasound scan and attend for follow-up.
You may not qualify if:
- Under 18 years of age or over 65 years of age
- Currently pregnant, actively trying to get pregnant, planning pregnancy within next 12 months or within 3 months of child-birth
- Current symptoms due to diagnosed gynaecological conditions
- Current or previous malignancy
- Unable or refuse to consent to trans-vaginal ultrasound scan or any other aspect of the study
- Previous abdominal or pelvic surgery (excluding diagnostic laparoscopy)
- Previous embolization of pelvic veins
- Previous deep vein thrombosis, pelvic embolisation, venous intervention in abdomen or pelvis (stent, filter)
- Any vascular malformation of the pelvis or the legs apart from that diagnosed as venous reflux disease.
- Any medical condition likely to cause death or serious ill health within the next five years.
- Any deep venous obstruction or reflux on duplex ultrasound.
- Unable to wear compression garments on lower abdomen / pelvis
- Unable to wear leg compression garments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Whiteley Cliniclead
- Bauerfeindcollaborator
Study Sites (1)
The Whiteley Clinic
Guildford, GU2 7RF, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Mark S Whiteley, MS FRCS(Gen) MBBS
The Whiteley Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2021
First Posted
September 23, 2022
Study Start
November 1, 2022
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
September 23, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share